• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG SHUNTASSISTANT 20; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG SHUNTASSISTANT 20; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FV251T
Device Problem Infusion or Flow Problem (2964)
Patient Problems Failure of Implant (1924); Patient Problem/Medical Problem (2688)
Event Date 08/20/2019
Event Type  Injury  
Manufacturer Narrative
Height: 81 cm.When additional information becomes available a follow up report will be submitted.
 
Event Description
It was reported that the valve was over draining.The reporter indicated that a 1 year 4 month post operative valve is over draining.Additional details of the event have not been provided.
 
Manufacturer Narrative
Investigation visual inspection no significant deformations or damage of the valve was detected during the visual inspection.Permeability test a permeability test has shown that the valve is permeable.Adjustment test this is a fixed pressure valve.An adjustment test is not applicable.Braking force and brake function test this is a fixed pressure valve.A braking force and brake function test is not applicable.Computer controlled test to investigate the claim of over-drainage, the opening pressure is measured using a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.The valve is tested in the vertical position.The results show that the valve is operating within the accepted tolerance in the vertical position.Results first, we performed a visual inspection of the shunt assistant.No significant deformations or damage of the valve were detected during the visual inspection.Next, we tested the permeability of the valve.The valve was shown to be permeable.Then we carried out a computer controlled simulated flow test.The measured opening pressure was within the accepted tolerance in the vertical positions.Finally, we have dismantled the valve.Inside the valve we have found slightly build-up of substances (likely protein).Based on our investigation, we are unable to substantiate the claim of over-drainage.At the time of our investigation, the valve was operating within the specified tolerances.The observed deposits in the valve could have been a cause of the valve's temporary malfunction.As described in the scientific literature, the problem encountered is one of the known, inevitable risks of hc-therapy by shunt implants.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SHUNTASSISTANT 20
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM  14469
MDR Report Key8962882
MDR Text Key156904541
Report Number3004721439-2019-00218
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K110206
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 09/17/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/04/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/01/2023
Device Model NumberFV251T
Device Catalogue NumberFV251T
Device Lot Number20036148
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/21/2019
Date Manufacturer Received09/02/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age12 MO
Patient Weight11
-
-